Skip to content

Released Feb 22, 2018, after the close

10-K filed Feb 22, 2018, 53 days after period end · 0001558370-18-000927

Q4 2017 · 10-K
Revenue$94.21M+7.7% vs Q4 2016+8.5% vs Q3 2017
Net Income$12.09MN/M vs Q4 2016N/M vs Q3 2017
EPS Diluted$0.08N/M vs Q4 2016N/M vs Q3 2017
Operating Incomederived$84,787,000N/M
Operating Cash Flowderived-$9,214,000N/M
Free Cash Flowderived-$8,808,000N/M
Margins · derived
Operating margin90.0%+97.2 pt vs Q4 2016
Net margin12.8%+28.3 pt vs Q4 2016

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2017Q4 2016Q4 2015Q4 2014
Revenue$94.21M$87.46M$53.31M$38.07M
Net Income$12.09M-$13.51M——
EPS Diluted$0.08-$0.09-$0.09-$0.27

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR